(Q46881248)

26 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy (English)

1 reference

26 December 2017

11

Ann Marie Schmidt

1 reference

26 December 2017

author name string

Cory Toth

1

1 reference

26 December 2017

Ling Ling Rong

2

1 reference

26 December 2017

Christina Yang

3

1 reference

26 December 2017

Jose Martinez

4

1 reference

26 December 2017

Fei Song

5

1 reference

26 December 2017

Noor Ramji

6

1 reference

26 December 2017

Valentine Brussee

7

1 reference

26 December 2017

Wei Liu

8

1 reference

26 December 2017

Jeff Durand

9

1 reference

26 December 2017

Minh Dang Nguyen

10

1 reference

26 December 2017

Douglas W Zochodne

12

1 reference

26 December 2017

language of work or name

English

0 references

publication date

26 November 2007

1 reference

26 December 2017

published in

Diabetes

1 reference

26 December 2017

volume

57

1 reference

26 December 2017

page(s)

1002-1017

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Tumor necrosis factor alpha and human Schwann cells: signalling and phenotype modulation without cell death

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Diabetes, advanced glycation endproducts and vascular disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Advanced glycation end products and the progressive course of renal disease.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Enhanced inflammatory response via activation of NF-kappaB in acute experimental diabetic neuropathy subjected to ischemia-reperfusion injury

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Endoplasmic reticulum D-myo-inositol 1,4,5-trisphosphate-sensitive stores regulate nuclear factor-kappaB binding activity in a calcium-independent manner

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT 2 receptor and the transcription factor NF‐κB

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Diabetes mellitus and the sensory neuron

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Remote neurotrophic support of epidermal nerve fibres in experimental diabetes.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

RAGE axis: Animal models and novel insights into the vascular complications of diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Normal blood flow but lower oxygen tension in diabetes of young rats: microenvironment and the influence of sympathectomy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells. Inhibitory effect of gliclazide

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Role of oxidative stress in advanced glycation end product-induced mesangial cell activation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB07-0339

Identifiers

DOI

10.2337/DB07-0339

1 reference

26 December 2017

PubMed ID

18039814

1 reference

26 December 2017